Seelaus Asset Management LLC Gilead Sciences, Inc. Transaction History

Seelaus Asset Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $198,164 - $228,697	3,138 New	3,138 $215,000
Q1 2023 Apr 19, 2023	BUY	$77.31 - $88.08 $231 - $264	3 Added 0.11%	2,723 $228,000
Q4 2022 Jan 19, 2023	BUY	$62.32 - $89.47 $169,510 - $243,358	2,720 New	2,720 $234,000
Q4 2021 Jan 10, 2022	SELL	$64.88 - $73.64 $591,056 - $670,860	-9,110 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$67.69 - $73.03 $28,768 - $31,037	425 Added 4.89%	9,110 $636,000
Q2 2021 Jul 27, 2021	BUY	$63.47 - $69.35 $46,650 - $50,972	735 Added 9.25%	8,685 $598,000
Q1 2021 Apr 26, 2021	BUY	$60.0 - $68.46 $20,100 - $22,934	335 Added 4.4%	7,950 $514,000
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $13,312 - $15,169	-235 Reduced 2.99%	7,615 $444,000
Q3 2020 Nov 05, 2020	BUY	$62.1 - $78.08 $487,485 - $612,928	7,850 New	7,850 $496,000
Q2 2018 Jul 18, 2018	SELL	$64.88 - $75.68 $183,610 - $214,174	-2,830 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$72.84 - $88.8 $2,185 - $2,664	30 Added 1.07%	2,830 $213,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $199,220 - $233,856	2,800	2,800 $201,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Seelaus Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Seelaus Asset Management LLC with notifications on news.